Nurse Practitioner · Charlotte, NC
NPI
1558534768
Since 2008
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
300 Billingsley Rd Ste 200
Charlotte, NC, 28211
Phone (704) 372-7974
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
339 services
Medicare patients, 2024
216
Average age 70
Drug cost, 2024
$987K
2,848 prescriptions
Company payments, 2025
$7,282
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geovanna Deese was code 99214 (office e&m - established), 249 times for 152 patients. In total Geovanna Deese billed 339 services in 11 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 249 | 152 | $76.74 | $19K |
| 99204 Office E&M - New | Office | 61 | 61 | $84.84 | $5,175 |
By year: 2022 $39K for 470 services; 2023 $31K for 429 services; 2024 $26K for 339 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geovanna Deese prescribed most often to Medicare patients was Pantoprazole Sodium, with 386 prescriptions and refills. In total Geovanna Deese wrote 2,848 Medicare prescriptions that cost $987K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 386 | 770 | 114 | $2,854 |
| Omeprazole Generic | 352 | 733 | 124 | $3,862 |
| Linzess Linaclotide | 233 | 452 | 93 | $241K |
| Dicyclomine Hcl Generic | 223 | 347 | 85 | $4,142 |
| Famotidine Generic | 166 | 282 | 45 | $2,149 |
| Lubiprostone Generic | 104 | 162 | 48 | $14K |
| Bethanechol Chloride Generic | 101 | 205 | 35 | $5,700 |
| Trulance Plecanatide | 90 | 151 | 24 | $83K |
| Metoclopramide Hcl Generic | 89 | 120 | 22 | $466 |
| Sucralfate Generic | 77 | 110 | 40 | $11K |
| Dexlansoprazole Dr Dexlansoprazole | 73 | 128 | 18 | $19K |
| Esomeprazole Magnesium Generic | 64 | 146 | 20 | $1,931 |
| Ondansetron Hcl Generic | 55 | 60 | 35 | $1,166 |
| Ibsrela Tenapanor Hcl | 51 | 61 | 15 | $107K |
| Spironolactone Generic | 46 | 63 | Under 11 | $349 |
Brand drugs: - claims; generic drugs: 2,142 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geovanna Deese $7,282 ($7,282 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $1,885.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 94 | $1,885 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 43 | $673 |
| Madrigal Pharmaceuticals MDGL | 20 | $554 |
| Janssen Biotech, Inc. JNJ | 19 | $535 |
| Aimmune Therapeutics, Inc. | 19 | $514 |
| QOL Medical, LLC | 19 | $438 |
| Vivus LLC | 19 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $366 |
| Phathom Pharmaceuticals, Inc. PHAT | 15 | $358 |
| Lilly USA, LLC LLY | 14 | $349 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.